Outpatient medications associated with protection from COVID-19 hospitalization

The COVID-19 pandemic remains the pre-eminent global health problem, and yet after more than three years there is still no prophylactic agent against the disease aside from vaccines. The objective of this study was to evaluate whether pre-existing, outpatient medications approved by the US Food and...

Descripción completa

Detalles Bibliográficos
Autores principales: Sandhu, Harpal Singh, Lambert, Joshua, Steckler, Zach, Park, Lee, Stromberg, Arnold, Ramirez, Julio, Yang, Chi-fu Jeffrey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10065249/
https://www.ncbi.nlm.nih.gov/pubmed/37000808
http://dx.doi.org/10.1371/journal.pone.0282961

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10065249/
https://www.ncbi.nlm.nih.gov/pubmed/37000808
http://dx.doi.org/10.1371/journal.pone.0282961

Ejemplares similares